Careers  |  Sign In  |  Register

Latest in Oncology

Jorge Cortes, MD, director of the Georgia Cancer Center in Augusta, GA, provides a comprehensive look at the current challenges specialists face in providing optimal treatment for patients with acute myeloid leukemia (AML). Dr. Cortes also discusses some history of AML research and treatment, the most recent...
The National Cancer Institute has developed a cloud-based infrastructure, the Cancer Research Data Commons, which allows cancer researchers to access, share, and analyze data from a centralized location, without the need to download or store vast stores of data.

PD-1 Immune Therapies May Leave Gap in Treatment of RCC

Dr. Braun on Unanswered Questions With PD-1 Blockade in Advanced RCC

David A. Braun, MD, PhD, physician at Dana-Farber Cancer Institute and instructor of medicine at Harvard Medical School, explains that while PD-1 blockade and immune therapies have been transformative for the treatment of renal cell carcinoma (RCC), not all patients respond to these standards of care. Kidney...